
Tata 1mg, previously called 1mg, is one of India’s leading digital healthcare platforms that provides services and products ranging from online consultations via chats to pharmacy, and lab tests at home.
Founded in 2015 by Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan and headquartered in Gurugram, Haryana, the company offers easy access to healthcare information, services and products to over 1000 cities in India including Delhi, Mumbai, Bengaluru, and Hyderabad.
According to their website, they have delivered over 31 million orders in 1800+ cities and the platform has seen over 260 million visitors till now.
These orders include products from various verified and quality brands. The platform acts as a verified source for users to find medicines and also learn about the various diseases and their symptoms, causes, risk factors, treatments and alternative therapies.
During the pandemic, the company contributed to creating awareness, acting as a source of accurate information and teleconsultation and delivery of healthcare products to those in need.
Some of the investors in the company include Redwood Global Healthcare Fund, Bill & Melinda Gates Foundation, Tata Digital, and Maverick Ventures.
In June 2021, Tata Digital Limited acquired a 55% stake in the company and thus Tata 1mg was formed. The company turned unicorn after the funding round in September 2022. The major competitors of Tata 1mg are PharmEasy, Netmeds.com, Truemeds and MedPlus.
1mg News
- News(342)
- Videos(1)